E-LIB Suche - Ergebnisse für: Yuji Teraoka

1

Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanc..:

Yosuke Tamura ; Atsushi Ono ; Hikaru Nakahara...
https://www.mdpi.com/2072-6694/15/17/4234. , 2023

Link: https://doi.org/10.3390/..

2

Lenvatinib activates anti-tumor immunity by suppressing imm..:

Masami Yamauchi ; Atsushi Ono ; Kei Amioka...
https://doi.org/10.1038/s43856-023-00390-x. , 2023

Link: https://doi.org/10.1038/..

3

Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanc..:

Yosuke Tamura ; Atsushi Ono ; Hikaru Nakahara...
Cancer Therapy. , 2023

Link: https://doi.org/10.3390/..

4

Hepatic venous pressure gradient after balloon-occluded ret..:

Yuki Shirane ; Eisuke Murakami ; Michio Imamura...
https://doi.org/10.1186/s12876-022-02616-z. , 2022

Link: https://doi.org/10.1186/..

5

Patient-derived monoclonal antibody neutralizes HCV infecti..:

Hiroshi Yokokawa ; Midori Shinohara ; Yuji Teraoka...
https://doi.org/10.1371/journal.pone.0274283. , 2022

Link: https://doi.org/10.1371/..

6

Identification and monitoring of mutations in circulating c..:

Yasutoshi Fujii ; Atsushi Ono ; C. Nelson Hayes...
https://doi.org/10.1186/s13046-021-02016-3. , 2021

Link: https://doi.org/10.1186/..

7

Increasing incidence of non-HBV- and non-HCV-related hepato..:

Yuko Nagaoki ; Hideyuki Hyogo ; Yuwa Ando...
https://doi.org/10.1186/s12876-021-01884-5. , 2021

Link: https://doi.org/10.1186/..

8

Circulating cytokines and angiogenic factors based signatur..:

Atsushi Ono ; Hiroshi Aikata ; Masami Yamauchi...
https://doi.org/10.1177/1758835920922051. , 2020

Link: https://doi.org/10.1177/..

9

Evaluation of glycemic variability in chronic liver disease..:

Fumi Honda ; Akira Hiramatsu ; Hideyuki Hyogo...
http://europepmc.org/articles/PMC5882130?pdf=render. , 2018

Link: https://doi.org/10.1371/..

10

The risks of hepatocellular carcinoma development after HCV..:

Yuko Nagaoki ; Michio Imamura ; Hiroshi Aikata...
http://europepmc.org/articles/PMC5552231?pdf=render. , 2017

Link: https://doi.org/10.1371/..

11

Additional file 3 of Identification and monitoring of mutat..:

Yasutoshi Fujii (11032034) ; Atsushi Ono (775522) ; C. Nelson Hayes (8876258)...
https://figshare.com/articles/dataset/Additional_file_3_of_Identification_and_monitoring_of_mutations_in_circulating_cell-free_tumor_DNA_in_hepatocellular_carcinoma_treated_with_lenvatinib/14853368. , 2021

Link: https://doi.org/10.6084/..

12

Additional file 1 of Identification and monitoring of mutat..:

Yasutoshi Fujii (11032034) ; Atsushi Ono (775522) ; C. Nelson Hayes (8876258)...
https://figshare.com/articles/dataset/Additional_file_1_of_Identification_and_monitoring_of_mutations_in_circulating_cell-free_tumor_DNA_in_hepatocellular_carcinoma_treated_with_lenvatinib/14853362. , 2021

Link: https://doi.org/10.6084/..

13

Additional file 5 of Identification and monitoring of mutat..:

Yasutoshi Fujii (11032034) ; Atsushi Ono (775522) ; C. Nelson Hayes (8876258)...
https://figshare.com/articles/dataset/Additional_file_5_of_Identification_and_monitoring_of_mutations_in_circulating_cell-free_tumor_DNA_in_hepatocellular_carcinoma_treated_with_lenvatinib/14853374. , 2021

Link: https://doi.org/10.6084/..

14

Additional file 7 of Identification and monitoring of mutat..:

Yasutoshi Fujii (11032034) ; Atsushi Ono (775522) ; C. Nelson Hayes (8876258)...
https://figshare.com/articles/dataset/Additional_file_7_of_Identification_and_monitoring_of_mutations_in_circulating_cell-free_tumor_DNA_in_hepatocellular_carcinoma_treated_with_lenvatinib/14853380. , 2021

Link: https://doi.org/10.6084/..

15

Additional file 8 of Identification and monitoring of mutat..:

Yasutoshi Fujii (11032034) ; Atsushi Ono (775522) ; C. Nelson Hayes (8876258)...
https://figshare.com/articles/figure/Additional_file_8_of_Identification_and_monitoring_of_mutations_in_circulating_cell-free_tumor_DNA_in_hepatocellular_carcinoma_treated_with_lenvatinib/14853386. , 2021

Link: https://doi.org/10.6084/..